medical device

Solving the gap between a high-tech prototype and an approved clinical solution requires navigating a complex puzzle of global standards and evolving data requirements. Aixial delivers the agile clinical and regulatory strategy needed to fast-track your innovation to market.

Turning a tech concept into a lifesaving medical device requires a seamless path to compliance

True success demands more than just smart design, it requires a predictive approach to clinical evidence that outpaces regulatory shifts. Every day a device spends in development is a day it is missing from a patient’s treatment plan. Therefore, by synchronizing precision engineering with adaptive clinical execution, we can transform complex technology into validated medical devices that redefine patient care.

Navigating the complex realities of Medtech innovation

Innovators must navigate shifting global regulations like MDR/IVDR and FDA pathways, ensure absolute cybersecurity for connected software (SaMD), and prove device safety through rigorous human factors engineering.

Compounding this urgency, the rise of generative AI has triggered a scramble for new governance frameworks. Consequently, as regulators struggle to keep pace with these software breakthroughs, market timelines have become highly unpredictable, forcing companies to secure ironclad clinical evidence much earlier.

Why medical device leaders partner with Aixial?

To master this landscape, innovators need a clinical partner that treats compliance as a growth driver, not a bottleneck. To that end, Aixial turns these complex hurdles into a predictable pathway by delivering targeted expertise in study design, global regulatory strategy, and data management.

Indeed, whether it is conducting precise usability trials to eliminate use errors or gathering robust evidence to satisfy payers, our agile approach de-risks development at every stage. We streamline the entire clinical journey, thereby helping you get your breakthrough devices out of limbo and directly onto the market.

Our areas of expertise

To learn more about our positioning within the industry

Speak with our experts

Our Full-Spectrum MDR & IVDR Capabilities

At Aixial Group, we provide comprehensive regulatory and clinical support across the entire spectrum of medical technologies, mastering every risk classification under MDR and IVDR.

MDR – Class I: Support for low-risk equipment, reusable surgical instruments, and basic digital health applications.

MDR – Class IIa & IIb: Proven track record in moderate-risk devices, including hearing aids, ultrasound equipment, and Software as a Medical Device (SaMD).

MDR – Class III: High-end expertise for critical or implantable technologies like pacemakers, stents, and smart drug-delivery systems.

IVDR – Class A & B: Streamlined pathways for low-risk diagnostics, general lab equipment, and self-tests like pregnancy or cholesterol kits.

IVDR – Class C: Specialized performance studies for high-individual risk tools, including oncology Companion Diagnostics (CDx) and genetic testing.

IVDR – Class D: Robust clinical evidence management for high-public risk diagnostics, targeting life-threatening pathogens like HIV or Hepatitis.

Learn more about it

Benefits to partnering with us

Reduce HR burden

We handle recruitment and resource management in-house. This dedicated talent acquisition capability allows us to rapidly scale qualified clinical teams, ensuring seamless operational support and flexible FSP models.

Increase value for money

You pay strictly for the service and deliverables you need. This approach eliminates overhead costs, allowing you to maximise your clinical trial budgets through highly efficient, scalable resource models.

Develop economies of scale

We achieve productivity gains by operating tasks at high volume. Consequently, this optimised workflow reduces your operational costs while driving greater efficiency across your clinical programs.

Transfer risks

Through fixed-price packages, we assume part of the risks associated with the delivery. Thereby, you secure predictable clinical trial costs while ensuring high-quality, on-time project execution.

Q&A

What types of medical technologies does Aixial cover?

Our expertise spans the entire Medtech spectrum, including traditional medical devices (classes I to III), In Vitro Diagnostics (IVD), active implantable devices, connected health software (SaMD), and complex drug-device combination products.

What engagement models does Aixial Group offer to Medtech companies?

We understand that different projects require different levels of outsourcing. Accordingly, we provide three flexible operational models:

Consulting support: On-demand high-level strategic, regulatory, or medical writing expertise.

Full-Service CRO partnership: Managing your clinical trial end-to-end with our teams, technology, and project governance.

Functional Service Provision (FSP): Supplying dedicated, expert teams embedded into your own infrastructure to scale up specific functions (e.g., Biostatistics, Data Management, or Pharmacovigilance).

What is the difference between your flexible consulting and FSP models?

Understanding that resource needs fluctuate throughout a study, we offer distinct delivery frameworks designed to optimize operational efficiency and control costs. On one hand, our consulting support provides on-demand, high-level expertise for ad-hoc regulatory or strategic challenges; on the other hand, our Functional Service Provision (FSP) models grant organizations dedicated, long-term operational teams that seamlessly integrate into their existing internal workflows.

How does Aixial help accelerate the transition to MDR and IVDR?

We de-risk your regulatory journey by building a proactive clinical strategy from day one. To achieve this, Aixial manages the entire process, from designing robust PMCF studies and clinical evaluation reports (CER) to generating the high-quality data required by Notified Bodies. Ultimately, this comprehensive approach ensures you can secure or maintain your CE marking with complete confidence.

Can you support clinical trials for connected devices and software as a medical device (SaMD)?

Yes. We specifically specialize in validation strategies for digital health. To make this happen, our teams bridge the gap between clinical operations and technology, thereby ensuring your software or connected device meets strict global standards for data privacy, cybersecurity, and clinical efficacy.

What is your approach to human factors engineering (Usability)?

We integrate IEC 62366-1 compliance early in the clinical phase. In practice, Aixial designs and executes usability trials directly in real-world clinical environments in order to evaluate user-device interaction. By doing so, we successfully minimize use errors and prove safety before regulatory submission.

How do you handle unpredictable global timelines and shifting regulations?

Through agility. Indeed, rather than relying on rigid, traditional CRO models, we deploy flexible, localized clinical teams who understand regional nuances (FDA, European competent authorities). This expertise allows us to adapt your study design in real-time and, consequently, keep your project on schedule.